2024GINA建議原文：in adults, adolescents and children 6–11 years should not be managed with short-acting β2-agonist relievers (SABAs) alone. Inhaled corticosteroid (ICS)-containing therapy reduces the risk of severe exacerbations, and controls symptoms. See https://ginasthma.org/reports/

Global Initiative for Asthma